Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)

NCT00160563 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

207

Enrollment

INDUSTRY

Sponsor class

Stopped The predecessor study A00309 (NCT00152464) did not show statistical significance in time to onset of asthma between the levocetirizine and placebo groups.

Conditions

Asthma

Interventions

DRUG: LEVOCETIRIZINE
OTHER: Placebo

Sponsor

UCB Pharma